Biostar Pharmaceuticals, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2017. For the quarter, the company reported loss from operations of $1,039,801 against $668,518 a year ago. Loss before income taxes was $1,014,150 against $678,566 a year ago. Net loss was $1,014,150 or $0.38 per basic and diluted share against $620,341 or $0.28 per basic and diluted share a year ago. Net cash provided by operating activities was $321,129 against $342,822 a year ago.